Currently accepted at: JMIR Aging
Date Submitted: Jul 30, 2026
Open Peer Review Period: Oct 5, 2026 - Nov 30, 2026
Date Accepted: Nov 16, 2026
(currently open for review)
This paper has been accepted and is currently in production.
It will appear shortly on 10.2196/104737
The final accepted version (not copyedited yet) is in this tab.
Development, Usability Testing, and Pilot Randomized Controlled Trial of WeCareToFeedDysphagia: A Web-Based Tool to Reduce Burden in Caregivers of Community-Dwelling Persons with Dementia and Oropharyngeal Dysphagia
ABSTRACT
Background:
Oropharyngeal dysphagia (dysphagia) affects up to 86% of hospitalized patients with Alzheimer disease (AD) and AD-related dementias (AD/ADRD) and is a significant predictor of caregiver burden. Upon hospital discharge, caregivers face dramatic and persistent unmet dysphagia-related caregiving needs, yet no single comprehensive resource exists to address these needs.
Objective:
To develop (Aim 1), test the usability/acceptability (Aim 2), and conduct a pilot feasibility randomized controlled trial (RCT; Aim 3) of a web-based caregiver tool for feeding in dysphagia (WeCareToFeedDysphagia), designed to reduce burden in caregivers of community-dwelling persons with AD/ADRD and dysphagia.
Methods:
The study was conducted in three phases: (1) semi-structured interviews with 15 caregivers to develop website content; (2) usability/acceptability testing with 20 caregivers (all 20 completed Round 1) using the think-aloud method, discrete navigation tasks, and the System Usability Scale (SUS); and (3) a fully remote, two-arm pilot feasibility RCT (N=80) across 11 heterogeneous hospitals, randomizing caregivers to enhanced control (usual care + speech-language pathologist referral) or intervention (enhanced control + WeCareToFeedDysphagia), with assessments at baseline, 1-month, and 3-months post-hospital discharge. The primary objective of Aim 3 was to evaluate feasibility for a full-scale effectiveness RCT; clinical outcome analyses were exploratory.
Results:
Four primary qualitative themes emerged and consistent feedback was integrated: caregiver experience with dysphagia, dysphagia-related information gaps, hospital discharge deficiencies, and website content feedback. Among the 20 caregivers who completed usability testing, the average task success rate was 94% and the mean SUS score was 90.8 (SD=10.29), indicating high usability. In phase 3 (pilot feasibility RCT), we met 6 of 6 go/no-go feasibility milestones (i.e., consent rate, attrition, initial and follow-up text receipt, home page access, and tool engagement). The observed effect size (Cohen's d) for the exploratory primary clinical outcome (caregiver burden at 3 months) was -0.1 (95% CI: −0.6 to 0.4). Unadjusted, baseline-adjusted, and longitudinal analyses did not demonstrate statistically significant between-group differences in burden. A nominally significant difference was observed on the CarerQol-VAS happiness scale at 3 months (intervention 6.1 vs. control 4.9, mean difference:1.2, 95% CI: 0.1 to 2.3; P=.03); however, this finding was one of multiple exploratory comparisons without multiplicity adjustment and should be considered hypothesis-generating.
Conclusions:
To our knowledge, WeCareToFeedDysphagia is the first stakeholder-informed, evidence-based, centralized web-based tool for caregivers of persons with AD/ADRD and dysphagia. It demonstrated high usability and acceptability. The pilot feasibility RCT demonstrated strong feasibility, meeting all pre-specified go/no-go milestones. These findings support transition to an NIH Stage IV (R33) full-scale effectiveness RCT (N=802). Clinical Trial: ClinicalTrials.gov NCT06557863; https://clinicaltrials.gov/study/NCT06557863
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.